16
Sun, Jun
67 New Articles

2022 was a busy year marked by the late effects of the covid-19 pandemic and the Russia-Ukraine conflict. The latter has led to the rethinking of energy matters. Austrian legislation in 2022 was, therefore, characterised above all by new developments and amendments in energy law, with a focus on the expansion of renewable energy. This article is part of a series on developments in Austrian environment and climate change law in 2022 and, in particular, focuses on legislative developments.

Wolf Theiss has advised the JP Hospitality Investors Club and the JP Immobilien Group on two hotel development and lease agreements for projects in Kitzbuehel and Trieste. DSC Doralt Seist Csoklich and Graf von Westphalen reportedly advised the two hotel operators.

Wolf Theiss, working with Clifford Chance, has advised private equity investor Altor – on behalf of Altor Funds – on the acquisition of an 80% majority stake in Kommunalkredit Austria and entering into a partnership with the existing owners and the management of the bank.

The ascendant popularity of ESG across business sectors has also empowered the rise of its evil twin: greenwashing. To look at the interplay between the two and their implications for the pharma industry in CEE, we sat down with CMS Partners Gabriela Staber and Tomas Matejovsky. 

Waste transports with a total quantity of more than 10 tonnes must be carried out by rail or other means of transport with equivalent or lower pollutant or greenhouse gas potential (e.g. propulsion by means of fuel cell or electric motor). The decisive factor is the transport distance covered in Austria, which will gradually decrease. From 1 January 2023, this obligation applies to a transport distance of 300 km or more; from 1 January 2024, the distance will be only 200 km.

Klara Kiehl, Clemens Rainer, Sascha Schulz, and Marco Thorbauer have been appointed as Schoenherr Partners in Austria, while Serbia's Jelena Arsic, Jovan Barovic, and Dusan Obradovic, Bulgaria's Tsvetan Krumov, and Hungary's Laszlo Krupl have all been appointed as Local Partners with the firm.

On January 4, CEE Legal Matters reported that Dorda, working with Loyens & Loeff, had advised Croma-Pharma on entering into a business combination agreement with the European Healthcare Acquisition & Growth Company. CEE In-House Matters spoke with Andreas Prinz, Managing Director at Croma Pharma, to learn more about the deal.